CureVac BV (CVAC) has risen Monday morning, with the stock adding 2.26% in pre-market trading to 45.18. CVAC's short-term technical score of 17 indicates that the stock has traded less bullishly over the last month than 83% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, the stock ranks higher than 35% of stocks. CureVac BV has risen 10.26% over the past month, closing at $42.10 on November 1. During this period of time, the stock fell as low as $35.33 and as high as $46.55. CVAC has an average analyst recommendation of Sell. The company has an average price target of $53.00.
CVAC has an Overall Score of 25. Find out what this means to you and get the rest of the rankings on CVAC!